Articles From: Heritage Insurance Announces Assumption of 2,000 Commercial Residential Policies to Hershey Declares Quarterly Dividends


PASO ROBLES, Calif., Nov.
Sign-up for Heritage Oaks Bancorp Announces Share Repurchase Program investment picks
PASO ROBLES, Calif., Oct.
Sign-up for Heritage Oaks Bancorp Reports Third Quarter Results investment picks
PASO ROBLES, Calif., Oct.
Sign-up for Heritage Oaks Bancorp Schedules Third Quarter Conference Call investment picks
ELGIN, Ill., Oct.
Sign-up for Heritage-Crystal Clean, Inc. Acquires FCC Environmental for $90 Million investment picks
ELGIN, Ill., Oct.
Sign-up for Heritage-Crystal Clean, Inc. Announces 2014 Third Quarter Financial Results investment picks
ELGIN, Ill., Dec.
Sign-up for Heritage-Crystal Clean, Inc. Announces Public Offering of Common Stock investment picks
ELGIN, Ill., Oct.
Sign-up for Heritage-Crystal Clean, Inc. to Hold 2014 Third Quarter Conference Call investment picks
Webcast to be held Thursday, September 18, 2014, at 9:30 AM EDT ZEELAND, Mich.
Sign-up for Herman Miller Reports Strategic Progress and Improved Momentum in the First Quarter of Fiscal Year 2015 investment picks
Heroku Shows Momentum in European Market with New Performance Tools to Support Enterprise-Class Applications at Scale European-based customers like Severn Trent Water, Toyota Motor Europe and TV4 use Heroku to build sophisticated applications to connect with their customers worldwide SAN FRANCISCO , Dec.
Sign-up for Heroku Announces General Availability of Performance Dynos in Europe investment picks
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, today reported third quarter and year-to-date 2014 financial results and highlighted recent corporate progress.
Sign-up for Heron Therapeutics Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate Highlights investment picks
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, today disclosed a development program for a P/neurokinin-1 (NK 1 ) receptor antagonist, which is used in the prevention of both acute- and delayed-onset chemotherapy induced nausea and vomiting (CINV). NK 1 receptor antagonists are administered in combination with a 5-HT 3 receptor antagonist for the prevention of CINV.
Sign-up for Heron Therapeutics Discloses New Proprietary Intravenous Formulation of NK-1 Receptor Antagonist for Prevention of CINV investment picks
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, announced today that Barry D.
Sign-up for Heron Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference investment picks
Héroux-Devtek announces the nomination of Martin Brassard as Vice-President and Chief Operating Officer Canada NewsWire LONGUEUIL, QC , Nov.
Sign-up for Héroux-Devtek announces the nomination of Martin Brassard as Vice-President and Chief Operating Officer investment picks
Héroux-Devtek reports fiscal 2015 second quarter results Canada NewsWire LONGUEUIL, QC , Nov.
Sign-up for Héroux-Devtek reports fiscal 2015 second quarter results investment picks
2014/11/7
Héroux-Devtek will hold a conference call to discuss its second quarter results ended September 30, 2014 Canada NewsWire OPEN TO: Analysts, investors and all interested parties DATE: Friday, November 14, 2014 TIME: 10:00 AM Eastern Time CALL: 514-807-9895 (FOR ALL MONTREAL AND OVERSEAS PARTICIPANTS) 1-888-231-8191 (FOR ALL OTHER NORTH AMERICAN CALLS) THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE CALL, THROUGH CNW.
Sign-up for Héroux-Devtek will hold a conference call to discuss its second quarter results ended September 30, 2014 investment picks
2014/9/22
Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of upscale hotels in urban gateway markets, today announced that its Board of Trustees declared an increased quarterly cash dividend of $0.07 per Common Share and per Limited Partnership Unit for the third quarter ending September 30, 2014.
Sign-up for Hersha Hospitality Trust Announces Increase In Quarterly Dividend investment picks
2014/12/11
Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of upscale hotels in urban gateway markets, today announced that its Board of Trustees declared a cash dividend of $0.50 per Series B Preferred Share and $0.4297 per Series C Preferred Share for the fourth quarter ending December 31, 2014.
Sign-up for Hersha Hospitality Trust Announces Quarterly Dividend investment picks
2014/10/29
Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of upscale hotels in urban gateway markets, today announced results for the third quarter ended September 30, 2014.
Sign-up for Hersha Hospitality Trust Announces Third Quarter 2014 Results investment picks
2014/10/8
Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of upscale hotels in urban gateway markets, will host an Investor Day today from 10:00 a.m. – 2:00 p.m. at The Rittenhouse in Philadelphia, PA.
Sign-up for Hersha Hospitality Trust Hosts Investor Day and Announces Preliminary Third Quarter 2014 Results investment picks
2014/10/1
Hersha Hospitality Trust (NYSE: HT) (“Hersha”, the “Company”), owner of upscale hotels in urban gateway markets, announced that the Company will release its financial results for the third quarter 2014 after the market close on Wednesday, October 29, 2014.
Sign-up for Hersha Hospitality Trust to Report Third Quarter 2014 Earnings on October 29, 2014 investment picks
The Hershey Company: Extends Hershey’s Sweets & Refreshment manufacturing capacity in North America Adds famous Canadian confectionery brands to the Hershey portfolio The Hershey Company (NYSE: HSY), a global confectionery leader known for bringing goodness to the world through its delicious chocolate, sweets, mints, beverages and snacks, announced today that it has completed the purchase of The Allan Candy Company, a leading North American manufacturer of quality confectionery products based in Ontario, Canada.
Sign-up for Hershey Acquires Iconic Canadian Confectionery Manufacturer Allan Candy Company investment picks
The Hershey Company (NYSE: HSY) today announced a new palm oil sourcing policy that updates and strengthens its commitment to source 100 percent traceable and responsible palm oil, a commitment the company announced in December 2013.
Sign-up for Hershey Announces Enhanced Palm Oil Sourcing Policy investment picks
The Hershey Company (NYSE: HSY): Net sales increase 5.8%; excluding a 0.2 point negative impact from foreign currency exchange rates, organic net sales up 6.0% Earnings per share-diluted of $1.00 as reported and $1.05 adjusted Outlook for 2014 net sales and adjusted earnings per share-diluted updated: Full-year net sales are expected to increase around 4.75%, including the impact of foreign currency exchange rates and a contribution from acquisitions of about 0.75 points Adjusted earnings per share-diluted expected to increase around 8% Net sales for 2015 expected to increase 7% to 9%, including the impact of foreign currency exchange rates and a contribution from
Sign-up for Hershey Announces Third-Quarter Results investment picks
The Hershey Company (NYSE: HSY) today announced President and CEO J.P. Bilbrey’s recent appointment by the U.S. Secretary of Commerce to the newly established President’s Advisory Council on Doing Business in Africa (PAC-DBIA). The private-sector advisory council will focus on strengthening the United States’ commercial relationships with African nations.
Sign-up for Hershey CEO J.P. Bilbrey Appointed to President Obama’s Advisory Council on Advancing Business Priorities in Africa investment picks
The Board of Directors of The Hershey Company (NYSE: HSY) today announced quarterly dividends of $0.535 on the Common Stock and $0.486 on the Class B Common Stock.
Sign-up for Hershey Declares Quarterly Dividends investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Heritage Insurance Announces Assumption of 2,000 Commercial Residential Policies to Hershey Declares Quarterly Dividends
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent